Management of spasticity in stroke.
Spasticity treatment must be considered in relation to other impairments with functional goals defined prior to intervention. The effects of muscle co-contraction and involuntary limb movement associated with exaggerated cutaneous reflexes or effort as well as stretch reflex hyperexcitability need to be considered. Exacerbating factors such as pain must be identified. Physical therapy and conventional orthoses are the mainstays of spasticity management during acute rehabilitation. Botulinum toxin shows promise but needs further evaluation in the context of acute rehabilitation. Phenol chemodenervation can produce good results in spasticity refractory to standard treatments. Muscle strengthening exercises may be appropriate in chronic hemiparesis without adversely affecting tone. Electrical stimulation may be a useful adjunct to other spasticity treatments. Difficulty demonstrating functional benefit from antispasticity treatment may imply that interventions directed at single motor impairments whether weakness or spasticity are not likely to result in functional benefit, but it is their combination that is important.
Bhakta
B B
BB
Rheumatology and Rehabilitation Research Unit, University of Leeds, UK.
D006801:Humans; D009128:Muscle Spasticity / Q000209:etiology / Q000534:rehabilitation / Q000628:therapy*; D026741:Physical Therapy Modalities / Q000379:methods; D020521:Stroke / Q000150:complications*; D000071939:Stroke Rehabilitation